Alpa Laboratories Ltd share price logo

Alpa Laboratories Share Price

NSE: ALPA

BSE: 532878

Small Cap

Healthcare Sector

₹76.45

+0.56

(+0.74%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Alpa Laboratories Stock Performance

as on January 7, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹75.89
    ₹77
    downward going graph

    0.73%

    Downside

    0.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹75
    ₹137.3
    downward going graph

    1.90%

    Downside

    79.59%

    Upside

    downward going graph

Alpa Laboratories share price movements today

Previous Close
₹75.89
Open
₹75.89
Volume
6,469.00
Upper Circuit
₹91.06
Lower Circuit
₹60.72
Day's Low - High
₹75.89 - ₹77
52 Week Low - High
₹75 - ₹137.3

Alpa Laboratories Historical Returns

1 Month Return
-4.16 %
3 Month Return
-14.97 %
1 Year Return
-43.57 %
3 Year Return
+ 24.92 %
5 Year Return
+ 96.86 %

Alpa Laboratories Fundamentals

as on January 7, 2026 at 4:01 pm IST

Market Cap

₹159.68 Cr

Return on Equity (ROE)

11.45

PE Ratio (TTM)

8.51

Return on capital employed (ROCE)

14.96

Industry PE ratio

41.96

Beta (LTM)

1.2

P/B Ratio

1.2

Dividend Yield

0

PEG Ratio

-8.18

Quarterly Earnings Growth YOY

-98.57

EPS (TTM)

9.27

Sector

Pharmaceuticals

Book Value

81.48

Technical Analysis

Bearish

View Technical Analysis

Alpa Laboratories Stock Valuation

as on January 7, 2026 at 4:01 pm IST

Alpa Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (7.21x)

September 29, 2025

Today (8.51x)

January 6, 2026

Industry (41.96x)

January 6, 2026

Highest (65.88x)

July 22, 2019

LowHigh

Today’s Price to Earnings Ratio: 8.51x

Alpa Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alpa Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Alpa Laboratories Ltd image
Alpa Laboratories Ltd
NA159.6819.37%0.5019112
Fredun Pharmaceuticals Ltd image
Fredun Pharmaceuticals Ltd
NA824.3853.64%0.0015348
Sotac Pharmaceuticals Ltd image
Sotac Pharmaceuticals Ltd
NA136.030.39%0.74996
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA1,305.6653.3%0.5149465
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA614.8053.65%0.6024198
See all

Alpa Laboratories Share Price Target

Get share price movements and forecasts by analysts on Alpa Laboratories.

Source: S&P Global Market Intelligence

Alpa Laboratories Stock’s Investor Sentiment and Interest

Search interest for Alpa Laboratories Ltd Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-35% versus previous 30 day period

Alpa Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
29.16
25.43
32.39
27.31
23.61
21.44
24.94
26.15
39.92
19.11
26.26
Other Income
-0.69
4.47
2.95
3.55
3.98
5.16
6.91
8.8
2.48
11.94
3.06
Total Income
28.47
29.9
35.35
30.86
27.59
26.6
31.85
34.95
42.4
31.06
29.32
Expenses
19.95
26.57
29.04
24.88
20.1
20.91
21.62
25.41
39.72
18.69
28.5
Operating Profit
9.21
-1.14
3.35
2.43
3.51
0.53
3.32
0.74
0.2
0.42
-2.24
Operating Profit Margin %
31.58%
-4.48%
10.34%
8.9%
14.87%
2.47%
13.31%
2.83%
0.5%
2.2%
-8.53%
Profit Before Interest, Tax and Depreciation
8.52
3.33
6.31
5.98
7.49
5.69
10.23
9.54
2.67
12.37
0.82
Interest
0.04
0.02
0.02
0.02
0.29
0.05
0.05
0.09
0.02
0.05
0.03
Depreciation
0.53
0.28
0.49
0.66
0.52
0.54
0.53
0.55
0.58
0.55
0.67
Profit Before Tax
7.95
3.03
5.8
5.3
6.68
5.1
9.65
8.9
2.07
11.77
0.12
Tax Paid
3.31
-
-
0.79
3.12
-
1.96
-
4.2
-
-
Profit After Tax
4.65
3.03
5.79
4.51
3.55
5.1
7.69
8.9
-2.12
11.77
0.11
Total Net profit including share of profit / Loss from associate company
4.65
3.03
5.79
4.51
3.55
5.1
7.69
8.9
-2.12
11.77
0.11
EPS
2.12
1.44
2.75
2.17
1.71
2.42
3.66
4.23
-0.95
5.59
0.05
Actual EPS
2.12
1.44
2.75
2.17
1.71
2.42
3.66
4.23
-0.95
5.59
0.05
Adjusted EPS
2.12
1.44
2.75
2.17
1.71
2.42
3.66
4.23
-0.95
5.59
0.05
Diluted EPS
2.12
1.44
2.75
2.17
1.71
2.42
3.66
4.23
-0.95
5.59
0.05

Alpa Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
63.45
62.85
77.99
85.97
97.55
112.27
92.44
108.74
112.45
Other Income
5.14
4.64
5.3
2.91
4.4
10.78
9.93
14.89
23.35
Total Income
68.59
67.48
83.29
88.88
101.95
123.04
102.37
123.63
135.8
Expenses
58.46
58.64
76.84
82.61
89.86
101.58
84.88
100.63
107.7
Operating Profit
4.99
4.21
1.15
3.36
7.69
10.69
7.56
8.11
4.75
Operating Profit Margin %
7.86%
6.7%
1.47%
3.91%
7.88%
9.52%
8.18%
7.46%
4.22%
Profit Before Interest, Tax and Depreciation
10.13
8.85
6.44
6.27
12.09
21.46
17.49
23
28.1
Interest
1.71
1.07
0.57
0.2
0.08
0.24
0.22
0.36
0.23
Depreciation
2.78
3.15
3.12
3.16
1.23
1.66
1.33
1.95
2.2
Profit Before Tax
5.64
4.63
2.75
2.91
10.78
19.56
15.94
20.69
25.67
Tax Paid
3.12
1.84
1.74
1.06
3.54
5.47
3.31
3.9
6.17
Profit After Tax
2.52
2.79
1.01
1.85
7.25
14.09
12.63
16.78
19.5
Total Net profit including share of profit / Loss from associate company
2.52
2.79
1.01
1.85
7.25
14.09
12.63
16.78
19.5
EPS
1.2
1.33
0.45
0.89
3.45
6.67
5.9
8.01
9.34
Actual EPS
1.2
1.33
0.45
0.89
3.45
6.67
5.9
8.01
9.34
Adjusted EPS
1.2
1.33
0.45
0.89
3.45
6.67
5.9
8.01
9.34
Diluted EPS
1.2
1.33
0.45
0.89
3.45
6.67
5.9
8.01
9.34

Alpa Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-21.85
16.99
-12.7
-1.01
17.78
-1.71
9.94
8.9
3.65
18.32
Cash Flow from Investing Activities
-8.03
-1.71
-11.47
-14.65
-11.17
5.86
-15.61
-0.43
-13.33
-12.36
Cash Flow from Financing Activities
-5.62
-15.23
8.83
-4.78
-1.35
0.19
5.44
-3.79
2.58
-5.44
Net Cash Flow
-35.5
0.05
-15.34
-20.44
5.27
4.34
-0.23
7.24
-7.1
0.51

Alpa Laboratories Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
57.29%
DII
0.01%
0.01%
0%
0%
0%
0%
0%
0%
0%
0%
0%
FII
0%
0%
0.11%
0%
0.5%
0.36%
0.74%
0.35%
0.4%
0.36%
0.35%
Public
42.69%
42.69%
42.6%
41.75%
42.2%
42.35%
41.96%
42.35%
42.31%
42.34%
42.35%
Total Outstanding Shares
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
2,10,40,600
Total Shareholders
19,137
18,745
18,565
18,682
18,690
18,116
18,885
19,206
18,872
18,851
18,542

Alpa Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Alpa Laboratories.

  • Alpa Laboratories Ltd Earnings Results

    Alpa Laboratories Ltd’s net profit fell -98.57% since last year same period to ₹0.11Cr in the Q2 2025-2026. On a quarterly growth basis, Alpa Laboratories Ltd has generated -99.07% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Alpa Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 42.34% to 42.35% in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 57.29% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 152.1% return, outperforming this stock by 127.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 15.7% return, outperforming this stock by 59.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 11.77 Cr → 0.11 Cr (in ₹), with an average decrease of 99.1% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.36% to 0.35% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 42.4 Cr → 29.32 Cr (in ₹), with an average decrease of 16.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, ALPA stock has moved down by -43.6%

About Alpa Laboratories Ltd

M/s Alpa Laboratories, established in 1967, was incorporated as a private limited company in 1988 and was converted to a public limited company in 1998. Their products include ethical drugs, generic drugs, OTC, and veterinary products in various dosage forms under the trade mark Alpa, which is a registered trademark owned by a promoter group company. They have also manufactured formulations for national and international companies such as Cipla and Zydus Cadila, and supplied contract manufacturing services in countries such as Liberia and Nigeria. The established product-marketing network covers both metro and mini metro cities, and business is categorized into Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The company commenced commercial production at their new Rau (Indore District, Madhya Pradesh) unit in 1999.

Revenue: ₹26.26Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.11Cr as on September 2025 (Q2 FY26)
Listing date: 06 Aug, 2007
Chairperson Name: Mahendra Singh Chawla
OrganisationAlpa Laboratories Ltd
HeadquartersIndore
IndustryPharmaceuticals
CEOMahendra Singh Chawla
E-voting on sharesClick here to vote

FAQs

What is Alpa Laboratories share price today?

Alpa Laboratories share price today stands at ₹76.45 as on at the close of the market. Alpa Laboratories share today touched a day high of ₹77 and a low of ₹75.89.

What is the 52 week high and 52 week low range for Alpa Laboratories share?

Alpa Laboratories touched a 52 week high of ₹137.3 and a 52 week low of ₹75. Alpa Laboratories share price today i.e. is closed at ₹76.45, which is -44.32% down from its 52 week high and 1.93% up from its 52 week low.

What is Alpa Laboratories's market capitalisation today?

Alpa Laboratories market capitalisation is ₹159.68 Cr as on .

How to buy Alpa Laboratories shares?

To buy Alpa Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ALPA or Alpa Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Alpa Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Alpa Laboratories trading volume today?

Alpa Laboratories trading volume is 6,469.00 as on . This means that 6,469.00 shares of Alpa Laboratories were bought and sold on the stock market during today's trading session.